Lista de obras -

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

artículo científico publicado en 2013

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Comparative efficacy of switching to natalizumab in active multiple sclerosis

artículo científico publicado en 2015

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Defining reliable disability outcomes in multiple sclerosis

artículo científico publicado en 2015

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

article

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

Geographical variations in sex ratio trends over time in multiple sclerosis.

artículo científico publicado en 2012

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

artículo científico publicado en 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients

artículo científico publicado en 2018

Increasing age at disability milestones among MS patients in the MSBase Registry

artículo científico

Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis

artículo científico publicado en 2010

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

artículo científico publicado en 2017

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

artículo científico publicado en 2015

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

artículo científico publicado en 2013

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

artículo científico publicado en 2013

Predictors of disability worsening in clinically isolated syndrome.

artículo científico publicado en 2015

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Risk of relapse phenotype recurrence in multiple sclerosis.

artículo científico publicado en 2014

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

artículo científico publicado en 2014

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

artículo científico publicado en 2013

The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review

scientific article published on 02 November 2019

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

artículo científico publicado en 2015

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

artículo científico publicado en 2017

Lista de obras de

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Comparative efficacy of switching to natalizumab in active multiple sclerosis

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Defining reliable disability outcomes in multiple sclerosis

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Geographical variations in sex ratio trends over time in multiple sclerosis.

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients

Increasing age at disability milestones among MS patients in the MSBase Registry

Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Predictors of disability worsening in clinically isolated syndrome.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Risk of relapse phenotype recurrence in multiple sclerosis.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.